A citation-based method for searching scientific literature

Monpat Chamnanphon, Andrea Gaedigk, Natchaya Vanwong, Nopphadol Nuntamool, Yaowaluck Hongkaew, Apichaya Puangpetch, Chonlaphat Sukasem. Pharmacogenomics 2018
Times Cited: 7







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
244
57

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Kelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, Jesse J Swen, Cyrine E Haidar, Teri E Klein, Roseann S Gammal, Mary V Relling, Stuart A Scott, Daniel L Hertz,[...]. Clin Transl Sci 2020
169
57

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
72
57


Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais.
Payiarat Suwannasri, Wanna Thongnoppakhun, Pornpen Pramyothin, Anunchai Assawamakin, Chanin Limwongse. Clin Biochem 2011
18
42

Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder.
Natchaya Vanwong, Nattawat Ngamsamut, Sadeep Medhasi, Apichaya Puangpetch, Montri Chamnanphon, Teerarat Tan-Kam, Yaowaluck Hongkaew, Penkhae Limsila, Chonlaphat Sukasem. J Child Adolesc Psychopharmacol 2017
19
42

Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease.
Yuan Zhong, Xueli Zheng, Ya Miao, Lili Wan, Hong Yan, Beiyun Wang. Am J Med Sci 2013
31
28

Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?
Laura Magliulo, Marja-Liisa Dahl, Grazia Lombardi, Silvia Fallarini, Laura Maria Villa, Aldo Biolcati, Maria Gabriella Scordo. Eur J Clin Pharmacol 2011
30
28

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
Muriel Noetzli, Monia Guidi, Karsten Ebbing, Stephan Eyer, Laurence Wilhelm, Agnès Michon, Valérie Thomazic, Ioana Stancu, Abdel-Messieh Alnawaqil, Christophe Bula,[...]. Br J Clin Pharmacol 2014
30
28

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Michael W Jann, Kara L Shirley, Gary W Small. Clin Pharmacokinet 2002
235
28

Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
Luís F J R Miranda, Karina B Gomes, Pedro A L Tito, Josianne N Silveira, Gerson A Pianetti, Ricardo M D Byrro, Patrícia R H Peles, Fernando H Pereira, Thiago R Santos, Arthur G Assini,[...]. J Alzheimers Dis 2017
13
28

Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients.
Federica Varsaldi, Gianluca Miglio, Maria Gabriella Scordo, Marja-Liisa Dahl, Laura Maria Villa, Aldo Biolcati, Grazia Lombardi. Eur J Clin Pharmacol 2006
73
28

Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
Zhiyong Xie, Qiongfeng Liao, Xinjun Xu, Meicun Yao, Jinzhi Wan, Dan Liu. Rapid Commun Mass Spectrom 2006
22
28


Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease.
A Coin, M V Pamio, C Alexopoulos, S Granziera, F Groppa, G de Rosa, A Girardi, G Sergi, E Manzato, R Padrini. Eur J Clin Pharmacol 2016
17
28

Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population.
Ha Hai Nguyen, Thuong Thi Huyen Ma, Nhung Phuong Vu, Quynh Thi Nhu Bach, Thang Hong Vu, Ton Dang Nguyen, Hai Van Nong. Medicine (Baltimore) 2019
8
28

Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
J Kevin Baird, Melva Louisa, Rintis Noviyanti, Lenny Ekawati, Iqbal Elyazar, Decy Subekti, Krisin Chand, Anggi Gayatri, Instiaty, Saraswati Soebianto,[...]. JAMA Netw Open 2018
52
28

8-Aminoquinoline Therapy for Latent Malaria.
J Kevin Baird. Clin Microbiol Rev 2019
40
28

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine.
Monpat Chamnanphon, Andrea Gaedigk, Apichaya Puangpetch, Ekawat Pasomsub, Wasun Chantratita, Rhea J Longley, Jetsumon Sattabongkot, Pajaree Chariyavilaskul, Chonlaphat Sukasem. Pharmgenomics Pers Med 2020
6
33

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
510
28

Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
Jason W Bennett, Brandon S Pybus, Anjali Yadava, Donna Tosh, Jason C Sousa, William F McCarthy, Gregory Deye, Victor Melendez, Christian F Ockenhouse. N Engl J Med 2013
183
28

CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
Johanna Sistonen, Antti Sajantila, Oscar Lao, Jukka Corander, Guido Barbujani, Silvia Fuselli. Pharmacogenet Genomics 2007
265
28

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Michele D Spring, Jessica T Lin, Jessica E Manning, Pattaraporn Vanachayangkul, Sok Somethy, Rathvicheth Bun, Youry Se, Soklyda Chann, Mali Ittiverakul, Piyaporn Sia-ngam,[...]. Lancet Infect Dis 2015
170
28

Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Eva Maria Staehli Hodel, Chantal Csajka, Frédéric Ariey, Monia Guidi, Abdunoor Mulokozi Kabanywanyi, Socheat Duong, Laurent Arthur Decosterd, Piero Olliaro, Hans-Peter Beck, Blaise Genton. Antimicrob Agents Chemother 2013
31
28

Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Sean R Marcsisin, Gregory Reichard, Brandon S Pybus. Pharmacol Ther 2016
64
28

Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
Michele D Spring, Jason C Sousa, Qigui Li, Christian A Darko, Meshell N Morrison, Sean R Marcsisin, Kristin T Mills, Brittney M Potter, Kristopher M Paolino, Patrick S Twomey,[...]. J Infect Dis 2019
16
28


Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.
Natchaya Vanwong, Nattawat Ngamsamut, Yaowaluck Hongkaew, Nopphadol Nuntamool, Apichaya Puangpetch, Montri Chamnanphon, Ananya Sinrachatanant, Penkhae Limsila, Chonlaphat Sukasem. Drug Metab Pharmacokinet 2016
20
28

Complexities of CYP2D6 gene analysis and interpretation.
Andrea Gaedigk. Int Rev Psychiatry 2013
138
28

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
Andrea Gaedigk, Magnus Ingelman-Sundberg, Neil A Miller, J Steven Leeder, Michelle Whirl-Carrillo, Teri E Klein. Clin Pharmacol Ther 2018
183
28

Practical interpretation of CYP2D6 haplotypes: Comparison and integration of automated and expert calling.
Gualberto Ruaño, Mohan Kocherla, James S Graydon, Theodore R Holford, Gregory S Makowski, John W Goethe. Clin Chim Acta 2016
11
28

Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.
Natchaya Vanwong, Santirat Prommas, Apichaya Puangpetch, Yaowaluck Hongkaew, Nopadol Nuntamool, Chalitpol Na Nakorn, Nattawat Ngamsamut, Penkhae Limsila, Chonlaphat Sukasem. J Clin Lab Anal 2016
10
28

A Review of the Important Role of CYP2D6 in Pharmacogenomics.
Christopher Taylor, Ian Crosby, Vincent Yip, Peter Maguire, Munir Pirmohamed, Richard M Turner. Genes (Basel) 2020
29
28

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer's disease.
Aleksandra Klimkowicz-Mrowiec, Pawel Wolkow, Malgorzata Sado, Anna Dziubek, Joanna Pera, Tomasz Dziedzic, Andrzej Szczudlik, Agnieszka Slowik. Neuropsychiatr Dis Treat 2013
16
14

CYP2D6 in the brain: genotype effects on resting brain perfusion.
J Kirchheiner, A Seeringer, A L Godoy, B Ohmle, C Maier, P Beschoner, E-J Sim, R Viviani. Mol Psychiatry 2011
39
14


Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.
Christa F Nagy, Dinesh Kumar, Carlos A Perdomo, Suman Wason, Edward I Cullen, Raymond D Pratt. Br J Clin Pharmacol 2004
21
14

Cognitive predictors of donepezil therapy response in Alzheimer disease.
Daniel Saumier, Susan Murtha, Howard Bergman, Natalie Phillips, Victor Whitehead, Howard Chertkow. Dement Geriatr Cogn Disord 2007
16
14


Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
N Mokhber, E Abdollahian, A Soltanifar, R Samadi, A Saghebi, M B Haghighi, A Azarpazhooh. Pharmacopsychiatry 2014
28
14

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
Chia-Chen Liu, Chia-Chan Liu, Takahisa Kanekiyo, Huaxi Xu, Guojun Bu. Nat Rev Neurol 2013
14

Alzheimer's disease.
Colin L Masters, Randall Bateman, Kaj Blennow, Christopher C Rowe, Reisa A Sperling, Jeffrey L Cummings. Nat Rev Dis Primers 2015
674
14

Global prevalence of dementia: a Delphi consensus study.
Cleusa P Ferri, Martin Prince, Carol Brayne, Henry Brodaty, Laura Fratiglioni, Mary Ganguli, Kathleen Hall, Kazuo Hasegawa, Hugh Hendrie, Yueqin Huang,[...]. Lancet 2005
14


CYP2D6 polymorphisms and the impact on tamoxifen therapy.
Jacob N Beverage, Tristan M Sissung, Amy M Sion, Romano Danesi, William D Figg. J Pharm Sci 2007
69
14


Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.
T Darreh-Shori, L Meurling, T Pettersson, K Hugosson, E Hellström-Lindahl, N Andreasen, L Minthon, A Nordberg. J Neural Transm (Vienna) 2006
57
14

Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.
Seiju Kobayashi, Masaru Tateno, Tae Woo Park, Kumiko Utsumi, Hitoshi Sohma, Yoichi M Ito, Yasuo Kokai, Toshikazu Saito. PLoS One 2011
23
14


Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.
Alberto Pilotto, M Franceschi, G D'Onofrio, A Bizzarro, F Mangialasche, L Cascavilla, F Paris, M G Matera, Andrea Pilotto, A Daniele,[...]. Neurology 2009
78
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.